2020
DOI: 10.1016/j.lfs.2020.117357
|View full text |Cite
|
Sign up to set email alerts
|

Schisantherin A causes endothelium-dependent and -independent vasorelaxation in isolated rat thoracic aorta

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
14
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(14 citation statements)
references
References 18 publications
0
14
0
Order By: Relevance
“…A vasorelaxant effect can be achieved by an endothelium-dependent (indirect vasodilators) or a non-endothelium-dependent (direct vasodilators) mechanism. In fact, endothelium-dependent vasorelaxation is mediated by endothelium-derived vasodilator factors, such as endothelium-derived hyperpolarizing factor, prostacyclin (PGI 2 ), and NO [ 48 , 49 ]. In other to get more insight into the vasorelaxant mechanism of the plant extracts, they were tested on aortic rings without endothelium and on aortic rings preincubated with L-NAME, an inhibitor of nitric oxide synthase.…”
Section: Discussionmentioning
confidence: 99%
“…A vasorelaxant effect can be achieved by an endothelium-dependent (indirect vasodilators) or a non-endothelium-dependent (direct vasodilators) mechanism. In fact, endothelium-dependent vasorelaxation is mediated by endothelium-derived vasodilator factors, such as endothelium-derived hyperpolarizing factor, prostacyclin (PGI 2 ), and NO [ 48 , 49 ]. In other to get more insight into the vasorelaxant mechanism of the plant extracts, they were tested on aortic rings without endothelium and on aortic rings preincubated with L-NAME, an inhibitor of nitric oxide synthase.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, isorhamnetin inhibited IP 3 -sensitive calcium pools from releasing calcium and protected endothelial cells (Jiayi et al, 2019). Schisantherin A (SCA) regulates NO and prostacyclin (PGI2) to induce endothelium-dependent vasodilation and obstructs VDCC to promote endothelium-independent vasodilation (Yang et al, 2020b). Thus, TCM can treat certain CVD conditions such as hypertensive heart disease by maintaining proper endothelial cell function through regulation of the calcium signaling pathway (Xiong et al, 2013;Yu et al, 2013;Zhang et al, 2020) (Figure 2).…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, the disturbance of calcium homeostasis has been observed in numerous types of CVDs, such as cardiac arrhythmias (Landstrom et al, 2017). Various studies have shown that Chinese herbal medicines and their active ingredients can improve cardiomyocyte function and treat CVDs by regulating the expression and activity of calcium channels and receptors (Hu et al, 2012;Yang et al, 2020b;Liu et al, 2013) (Figure 1). For example, senkyunolide A and ligustrazinecan hindered the opening of VDCC, rendering a calcium antagonistic effect (Lei et al, 2018).…”
Section: Discussionmentioning
confidence: 99%
“…The present study is the first to investigate the vasodilatory effect of GPS in Vasodilation can be divided into two types: endotheliumdependent and endothelium-independent. The former is mainly related to the production of endothelium-derived relaxing factor NO and prostaglandins in the thoracic aorta, while the latter is related to a reduction in [Ca 2+ ] in levels caused by drugs directly acting on VSM [29]. Contraction of VSM depends on the influx of extracellular Ca 2+ through VDCC and ROCC in the cell membrane and the release of intracellular Ca 2+ through stimulation of IP 3 R-and RYRmediated Ca 2+ channels in the sarcoplasmic reticulum [30].…”
Section: Discussionmentioning
confidence: 99%